Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Share-based Compensation

v3.10.0.1
Note 9 - Share-based Compensation
 6 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note
9.
Share-based Compensation:
 
During the 
six
months ended
December 31, 2018
and
2017,
the Company granted 
0.9
million and
1.0
million stock options at weighted average grant prices of
$174.10
and
$118.97
and weighted average fair values of
$34.69
and
$21.58,
respectively. During the
six
months ended
December 31, 2018
and
2017,
the Company granted 
53,903
and
35,674
restricted stock units at a weighted average fair value of
$170.74
and
$125.02,
respectively. During the
six
months ended
December 31, 2018
and
2017,
the Company granted
14,887
and
20,106
shares of restricted common stock shares at a grant date fair value of
$177.93
and
$125.05,
respectively.
 
Stock options for 
189,627
and
70,069
shares of common stock with total intrinsic values of
$16.3
million and
$2.8
million were exercised during the
six
months ended
December 31, 2018
and
2017,
respectively.
 
Stock-based compensation expense of
$6.9
million and
$5.0
million was included in selling, general and administrative expenses for the quarter ended
December 31, 2018
and
2017,
respectively. Stock-based compensation expense of
$18.4
million and
$8.8
million was included in selling, general, and administrative expenses for the
six
months ended
December 31, 2018
and
2017,
respectively. As of
December 31, 2018,
there was
$37.8
million of unrecognized compensation cost related to non-vested stock options, non-vested restricted stock units and non-vested restricted stock. The weighted average period over which the compensation cost is expected to be recognized is 
2.2
years.